141 related articles for article (PubMed ID: 30127978)
1. Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.
Xia HB; Wang HJ; Fu LQ; Wang SB; Li L; Ru GQ; He XL; Tong XM; Mou XZ; Huang DS
Oncol Lett; 2018 Sep; 16(3):3681-3689. PubMed ID: 30127978
[TBL] [Abstract][Full Text] [Related]
2. Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis.
Tezval H; Dubrowinskaja N; Peters I; Reese C; Serth K; Atschekzei F; Hennenlotter J; Stenzl A; Kuczyk MA; Serth J
PLoS One; 2016; 11(10):e0163873. PubMed ID: 27695045
[TBL] [Abstract][Full Text] [Related]
3. CRHBP is degraded via autophagy and exerts anti-hepatocellular carcinoma effects by reducing cyclin B2 expression and dissociating cyclin B2-CDK1 complex.
Wang Z; Li M; Liu Y; Qiao Z; Yang L; Liu B; Bai T
Cancer Gene Ther; 2022 Aug; 29(8-9):1217-1227. PubMed ID: 35082401
[TBL] [Abstract][Full Text] [Related]
4. Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer.
Tezval H; Atschekzei F; Peters I; Waalkes S; Hennenlotter J; Stenzl A; Becker JU; Merseburger AS; Kuczyk MA; Serth J
BMC Cancer; 2013 Apr; 13():199. PubMed ID: 23607589
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma.
Wang HJ; Wang L; Song SS; He XL; Pan HY; Hu ZM; Mou XZ
Cancer Biomark; 2018 Feb; 21(3):723-730. PubMed ID: 29278884
[TBL] [Abstract][Full Text] [Related]
6. Low
Cheng Y; Xing SG; Jia WD; Huang M; Bian NN
Onco Targets Ther; 2017; 10():47-54. PubMed ID: 28031722
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Zwint-1 is associated with poor prognosis in hepatocellular carcinoma.
Wang HJ; Wang L; Lv J; Fu LQ; Wang Z; He XL; Ma YY; Li L; Zhao TW; Xu XG; Yu LL; Pan HY; Hu ZM; Mou XZ
Int J Clin Exp Pathol; 2017; 10(10):10406-10412. PubMed ID: 31966377
[TBL] [Abstract][Full Text] [Related]
8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
9. Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
Liu Y; Hu C; Zhu WB; Xu WX; Li ZY; Lin Y; Cai J; Liang JK; Zhu X; Gao ZL; Yan GM; Peng L
Cell Physiol Biochem; 2018; 49(3):1007-1018. PubMed ID: 30196292
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer.
Faraj Tabrizi P; Mohebbi Tafrechi A; Peters I; Atschekzei F; Kuczyk MA; Serth J; Tezval H
Adv Ther; 2020 Jan; 37(1):288-299. PubMed ID: 31721113
[TBL] [Abstract][Full Text] [Related]
12. Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis.
Xia HB; Wang HJ; Song SS; Zhang JG; He XL; Hu ZM; Zhang CW; Huang DS; Mou XZ
Oncol Lett; 2020 Jan; 19(1):69-76. PubMed ID: 31897116
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
14. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
[TBL] [Abstract][Full Text] [Related]
15. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis.
Deng Y; Li AM; Zhao XM; Song ZJ; Liu SD
Oncol Lett; 2017 Mar; 13(3):1228-1234. PubMed ID: 28454239
[TBL] [Abstract][Full Text] [Related]
18. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
19. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris.
Ganceviciene R; Graziene V; Fimmel S; Zouboulis CC
Br J Dermatol; 2009 Feb; 160(2):345-52. PubMed ID: 19077080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
